CD8A and neoplasm: These data further support that the anti-PD-1 therapy enhanced MWA-induced anti-tumor effects based on adaptive CD8+T cell immune responses, and the chemokine CXCL10 contributed to the synergistic effect of ablation plus anti-PD-1 treatment.